Pfizer Stock: Rebound Has Started (Technical Analysis) [Seeking Alpha]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Seeking Alpha
The stock price has recently started rebounding from its low point and is showing bullish technical signs for continued momentum. Besides these technical signs, I also see fundamental catalysts that could support further price rallies. At current prices, the market has already factored in the potential headwinds judging by the pessimistic EPS outlook and the low P/E even assuming such an outlook. Its ongoing pipeline, especially the oncology pipeline with the Seagen acquisition, offers further upside potential. PFE stock: COVID-19 product demand deterioration Pfizer Inc. ( NYSE: PFE NEOE: PFE:CA ) is facing a challenging year ahead. Earnings and sales fell markedly last year due to the deterioration in demand for its COVID-19-related products. The market probably already saw Recommended For You Recommended For You
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pentagon ran secret anti-vaccine campaign to undermine China during COVID-19 pandemic, investigation finds [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails [Yahoo! Finance]Yahoo! Finance
- Is It Too Late to Buy Pfizer Stock? [Yahoo! Finance]Yahoo! Finance
- ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma [Yahoo! Finance]Yahoo! Finance
- ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple MyelomaBusiness Wire
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 6/11/24 - Form 11-K
- 6/11/24 - Form 11-K
- 6/4/24 - Form 4
- PFE's page on the SEC website